Conavi Medical Corp.
CNVIF
$0.2547
-$0.0053-2.04%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | ||
|---|---|---|---|---|---|
| Net Income | 34.17% | 31.90% | -124.18% | -- | |
| Total Depreciation and Amortization | -33.08% | -30.74% | 8.30% | -- | |
| Total Amortization of Deferred Charges | -- | -- | -80.62% | -- | |
| Total Other Non-Cash Items | -175.84% | -178.47% | 4,784.36% | -- | |
| Change in Net Operating Assets | 487.69% | 500.86% | -20.17% | -- | |
| Cash from Operations | -13.73% | -17.67% | 17.36% | -- | |
| Capital Expenditure | 82.98% | 82.39% | -1.57% | -- | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | 1,926.12% | 1,988.10% | -10.22% | -- | |
| Cash from Investing | 789.29% | 813.20% | -3.35% | -- | |
| Total Debt Issued | -- | -- | 767.32% | -- | |
| Total Debt Repaid | -47.61% | -47.61% | 50.87% | -- | |
| Issuance of Common Stock | 168,100.00% | 168,100.00% | -100.00% | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | |
| Cash from Financing | 1,722.16% | 1,778.25% | -80.07% | -- | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 105.01% | 105.18% | -111.63% | -- | |